Article Text

Reminder of important clinical lesson
X-linked adrenoleukodystrophy presenting as Addison’s disease
  1. Bernhard Kaspar Morell1,
  2. Jens Teichler2,
  3. Kemal Budak3,
  4. Jörg Vollenweider4,
  5. Vojtech Pavlicek5
  1. 1Kantonsspital Münsterlingen, Internal Medicine, Postfach, Münsterlingen, 8596, Switzerland
  2. 2Kinderspital Zürich, Neuropediatrics, Steinwiesstrasse 75, Zürich, 8032, Switzerland
  3. 3Universitätsspital Zürich, Internal Medicine, Rämistrasse 100, Zürich, 8091, Switzerland
  4. 4Private Practice, Alleestrasse 20, Romanshorn, 8590, Switzerland
  5. 5Endocrine Practice, Klosterhofstrasse 1, Kreuzlingen, 8280, Switzerland
  1. Correspondence to Bernhard Kaspar Morell, bernhardmorell{at}hotmail.com

Summary

We report the case of a young man with a history of attention deficit/hyperactivity disorder and mild cognitive impairment who presented with chronic fatigue, anorexia and progressive darkening of the skin. On laboratory testing, severely depressed concentrations of morning cortisol, along with highly elevated values of adrenocorticotropic hormone (ACTH) revealed primary adrenal insufficiency as the primary cause of the patient’s symptomatology. Imaging of the brain showed altered signal intensities in the parieto-occipital regions of the brain. The demonstration of increased very long chain fatty acids (VLCFA) established the diagnosis of adolescent X-linked adrenoleukodystrophy (X-ALD). Presenting at an advanced yet slowly progressive stage the patient was not a suitable candidate for haematopoietic stem cell transplantation (HSCT), and treatment focused on hormone replacement therapy, family counselling and supportive care. On follow-up visits within the following year, fatigue had diminished and there was no evidence of progressive neurological deficits. However, exacerbation of the psychiatric symptomatology resulted in admittance to a psychiatric ward.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: None.

  • Patient consent: Patient/guardian consent was obtained for publication.